Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
React to this article
Latest news
Date Title
04:33a MINISTRY OF MICRO SMALL AND MEDIUM ENTERPRISES OF : Memorandum of Understanding between India and Sweden on cooperation in the field of Micro, Small and Medium Enterprises
04:31a YOMA STRATEGIC : KFC first QSR to enter Myanmar
04:23a EMED MINING PUBLIC : Posting of Circular, Notice of EGM, Details of Open Offer
04:20a AUDI : UPDATED: Search on for driver in 5-car city pileup
04:20a MOODY : BRIEF: $250 million of city debt downgraded by Moody's
04:18a MINISTRY OF FINANCE OF REPUBLIC OF INDIA : Cabinet apprised of constitution of Committee under Chairpersonship of Prime Minister and activities to mark 125th Birth Anniversary year of Dr. B.R. Ambedkar
04:18a TATA MOTORS : launches new full-range Passenger Vehicle dealership in Mumbai
04:12a STATE BANK OF INDIA : Now, apply for SBI loans online
04:11a NCR : New weatherized ATM delivers full functionality in small footprint
04:11a MICROSOFT : ATMIA warns of end of support for older IE and .NET software
Latest news
Advertisement
Hot News 
IMMUNODIAGNOSTIC SYSTEMS HLDGS : Expects Further Revenue Fall In Current Year
HERON THERAPEUTICS : DE/ : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
ESSENDEN : 29 May 2015 - Rule 2.6 (c) - 2nd Extention
CLEARSTAR : Chairman Barney Quinn Buys Shares (DIRECTOR DEALINGS)
MINCO : 2015 Q1 MD&A Report
Most Read News
05/29 UGI : completes $465 million acquisition of French liquefied petroleum gas distribution business (BRIEF)
05/29 NATURALLY SPLENDID ENTERPRISES LTD : Naturally Splendid Launches Bulk Ingredient Division
05/29 PLATINO ENERGY : Files First Quarter 2015 Financials and MD&A
05/29 NATURALLY SPLENDID ENTERPRISES : Launches Bulk Ingredient Division
05/29 Strong sales could shift Ford, GM to higher gear
Most recommended articles
01:24a CHINA'S SLOWING ECONOMY MAY STEADY LATER THIS YEAR : state think tank
05/29 WEEKLY TRADING FORECAST : ECB, BoE, NFPs and Much More Ahead
05/29 US Dollar Breakout Velocity Rests with Fed’s Liftoff Outlook after NFPs
05/29 Strong sales could shift Ford, GM to higher gear
05/29 Merkel appeals to Germans to back trade pact ahead of G7 meeting